Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 17, Number 1—January 2011

Dispatch

Serologic Status for Pandemic (H1N1) 2009 Virus, Taiwan

Daniel Tsung-Ning Huang1, Pei-Lan Shao1, Kuo-Chin Huang, Chun-Yi Lu, Jen-Ren Wang, Shin-Ru Shih, Hsin Chi, Mei-Ru Lai, Chin-Yun Lee, Luan-Yin Chang, and Li-Min HuangComments to Author 
Author affiliations: Author affiliations: Mackay Memorial Hospital, Taipei, Taiwan (D.T.-N. Huang, H. Chi); National Taiwan University Hospital, Taipei (P.-L. Shao, K.-C. Huang, C.-Y. Lu, M.-R. Lai, C.-Y. Lee, L.-Y. Chang, L.-M. Huang); National Cheng Kung University, Tainan, Taiwan (J.-R. Wang); Chang-Gung Memorial Hospital, Taipei (S.-R. Shih); National Taiwan University, Taipei (L.-M. Huang)

Main Article

Figure

Seroprotection rates determined by hemagglutination inhibition (HI) assay (white bars) or microneutralization (MN) assay (gray bars) and geometric mean titer (GMT) of antibodies against pandemic (H1N1) 2009 virus in each 10-year age cohort, Taiwan, 2007–2008.

Figure. Seroprotection rates determined by hemagglutination inhibition (HI) assay (white bars) or microneutralization (MN) assay (gray bars) and geometric mean titer (GMT) of antibodies against pandemic (H1N1) 2009 virus in each 10-year age cohort, Taiwan, 2007–2008.

Main Article

1These authors contributed equally to this article.

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO